For decades, Chinese hamster ovary (CHO) cell lines have been ... the economics of drug production. Amyris cut its teeth engineering metabolic pathways in yeast to produce advanced biofuels ...

Amyris (AMRS) is an industrial biotechnology company. It genetically engineers yeast, so that instead of producing alcohol when it ferments, yeast produces other valuable chemicals instead.

Depending on their goals, engineers at Amyris can outfit the yeast with a variety of genetic material that tells the yeast how to digest what it is fed. The result is a cell that can (at least in ...

Amyris's grant share as of January 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents. A recent patent application (Publication Number: US20240035061A1) ...

The researchers created the yeast-based cell factories by inserting a large ... J.D.K. also has financial interests in Amyris, Lygos, Demetrix, Napigen, Apertor Pharmaceuticals, Maple Bio, Ansa ...

Amyris has been granted a patent for compositions and methods for producing myrcene. The patent involves genetically modified microbial host cells that express a myrcene synthase and optionally a ...

By Veronique Greenwood In a lab in Atlanta, thousands of yeast cells fight for their lives every day. The ones that live another day grow fastest, reproduce quickest and form the biggest clumps.